Framatome in Canada
Supporting nuclear excellence and innovation
In Canada, Framatome remains committed to supporting the regional economic growth, fostering employee well-being, and sustaining meaningful investment in local communities.
With roots going back to 1964, only two years after Ontario’s first power generating reactor went online, Framatome Canada Ltd. is a major provider of services and engineering for the Canadian and global CANDU market, as well as an integral partner in producing life-saving medical isotopes for cancer treatment worldwide.
Bold Energy. Bright Future.
160
employees
3
locations
53+
years supporting the Canadian fleet
Our activities in Canada
Framatome is known for its strong reputation and unwavering commitment to excellence and is positioned for long-term stability and success in a rapidly growing industry.
We CAN DO more than you realize!
Infographic presenting the different areas of expertise at Framatome in Canada and its CANDU Center of Excellence. 14 domains of expertise are listed here: Contaminated Refurbishment Center, Design and Engineering, Fuel Manufacturing, Full Scale Nuclear Laboratory, Global Team of Experts, Instrumentation and Control, Maintenance and Inspection, Manufacturing, New Builds and Engineering, Procurement, Construction (EPC), Nuclear Parts Center (NPC), Pump and Motor Service Center, Research and Development, Robotics and Tooling Design, Technical Training Center.
Supporting Canada’s nuclear future
Framatome has been an invested partner contributing to the delivery of carbon-free energy to Canada’s power grid for generations, with a broad and proven portfolio of refurbishment experience and solutions for life extension success. Its unique access to global experts and innovative technology allows Framatome to provide the Canadian marketplace with Engineering, Procurement and Construction (EPC) services under one umbrella.
Supporting the global CANDU fleet with sustainable nuclear technology, Framatome Canada delivers unlimited, state-of-the-art solutions in high voltage maintenance, general maintenance, rotating equipment, heavy and mobile component replacement, inspections, outage services and outage optimization.
Recent major projects:
- Steam generator replacements at Bruce Power
- Design and commissioning of Isotope Production Systems (IPS) in a commercial reactor at Bruce Power
- EPC work scopes supporting Pickering Refurbishment
Top supplier in maintenance and construction supporting main output and station service transformers and other major switchyard equipment
Innovative solutions
Framatome offers innovative solutions to Canadian challenges, leveraging our global experience:
- Isotope production systems
- Full-system decontamination
- Qualified liner and coating solutions
- Fully passive containment filtered venting systems
Producing life-saving medical isotopes
Isogen, a joint venture between Framatome and Kinectrics, is on a mission to enable the use of CANDU reactors to produce the medical isotopes needed to treat and diagnose patients with serious diseases world-wide. Isogen has successfully completed the world’s first Isotope Production System (IPS) installation within a commercial power reactor. The process inserts, irradiates and then removes targets without interrupting the power generation of the CANDU reactor.
Designed by Framatome, the IPS has been reliably creating life-saving Lutetium-177 (Lu-177), used to treat prostate cancer and neuroendocrine tumors. Isogen’s technology is adaptable and scalable, allowing the production of the world’s largest and most reliable supply of multiple life-saving medical isotopes needed to treat and diagnose patients with cancer and other serious diseases.
Industry-leading performance
Our local teams have been recognized many times for their expertise and capabilities :
- Recognized in high voltage work
- 10-time Outage Cup winners
- Client Directors Teamwork Award
- 2022 Top Innovative practice (TIP) Award for ISOGEN
- 2023 TIP Award for Containment Filtered Venting System (CFVS)
- 2023 World Nuclear Exhibition (WNE) Award for Fight Cancer (IPS)